Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The pharmacogenetics of antimalaria artemisinin combination therapy.

Expert opinion on drug metabolism & toxicology - 1 Oct 2011

Piedade Rita, Gil José Pedro

Abstract excerpt

INTRODUCTION: Plasmodium falciparum malaria is one of the world's most lethal infectious diseases, commanding millions of drug administrations per year. The pharmacogenetics of these drugs is poorly known, although its application can be pivotal for the optimized management of this disease. AREAS COVERED: The main components of artemisinin combination therapy (ACT), the worldwide main antimalarial strategy, are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fluorenes
Share to Aminoquinolines
Share to Artemisinins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Artesunate

Share to Cytochrome P-450 CYP2A6

Share to Cytochrome P-450 CYP2C8

Share to Ethanolamines

Share to Mefloquine

Source

Identifiers

PMID: 21899476
DOI: 10.1517/17425255.2011.608660

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The pharmacogenetics of antimalaria artemisinin combination therapy.PMID 21899476Read ↗

An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malariaSemantic proximity Read ↗

CYP2C8 and Antimalaria Drug EfficacySemantic proximity Read ↗

Amodiaquine pharmacogenetics.Semantic proximity Read ↗

Can pharmacogenomics improve malaria drug policy?Semantic proximity Read ↗

Plasmodium Genomics and Genetics: New Insights into Malaria Pathogenesis, Drug Resistance, Epidemiology, and EvolutionSemantic proximity Read ↗

A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications.Semantic proximity Read ↗

Polymorphisms in Cytochrome P450 genes: implications for Plasmodium vivax malaria treatment in Brazil.Semantic proximity Read ↗

Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles.Semantic proximity Read ↗

Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.Semantic proximity Read ↗

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.Semantic proximity Read ↗

Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015–2016Semantic proximity Read ↗

Artemisinin-Based Antimalarial Drug Therapy: Molecular Pharmacology and Evolving ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.